Contributions from the systematic review of economic evaluations: the case of childhood hepatitis A vaccination in Brazil


Autoria(s): De Soárez, Patrícia Coelho; Sartori, Ana Marli Christovam; Santos, Andreia; Itria, Alexander; Novaes, Hillegonda Maria Dutilh; Martelli, Celina Maria Turchi
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

04/11/2013

04/11/2013

2012

Resumo

The aim of this study was to present the contributions of the systematic review of economic evaluations to the development of a national study on childhood hepatitis A vaccination. A literature review was performed in EMBASE, MEDLINE, WOPEC, HealthSTAR, SciELO and LILACS from 1995 to 2010. Most of the studies (8 of 10) showed favorable cost-effectiveness results. Sensitivity analysis indicated that the most important parameters for the results were cost of the vaccine, hepatitis A incidence, and medical costs of the disease. Variability was observed in methodological characteristics and estimates of key variables among the 10 studies reviewed. It is not possible to generalize results or transfer epidemiological estimates of resource utilization and costs associated with hepatitis A to the local context. Systematic review of economic evaluation studies of hepatitis A vaccine demonstrated the need for a national analysis and provided input for the development of a new decision-making model for Brazil.

Identificador

Cad. Saúde Pública,v.28,n.2,p.211-228,2012

0102-311X

http://www.producao.usp.br/handle/BDPI/38917

10.1590/S0102-311X2012000200002

http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-311X2012000200002&lng=en&nrm=iso&tlng=en

http://www.scielo.br/scielo.php?script=sci_abstract&pid=S0102-311X2012000200002&lng=en&nrm=iso&tlng=en

http://www.scielo.br/scielo.php?script=sci_pdf&pid=S0102-311X2012000200002&lng=en&nrm=iso&tlng=en

Idioma(s)

eng

Publicador

Escola Nacional de Saúde Pública Sergio Arouca, Fundação Oswaldo Cruz

Relação

Cadernos de Saúde Pública

Direitos

openAccess

Palavras-Chave #Cost-Effectiveness Evaluation #Cost-Benefit Analysis #Hepatitis A #Immunization Programs #Avaliação de Custo-Efetividade #Análise Custo-Benefício #Hepatite A #Programas de Imunização
Tipo

article

original article